The Clorox Company $CLX Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC grew its position in The Clorox Company (NYSE:CLX) by 0.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,172,233 shares of the company’s stock after acquiring an additional 10,060 shares during the period. Geode Capital Management LLC owned about 2.62% of Clorox worth $318,613,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Center for Financial Planning Inc. acquired a new position in shares of Clorox in the third quarter worth about $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in shares of Clorox in the third quarter worth about $25,000. Darwin Wealth Management LLC acquired a new position in shares of Clorox in the second quarter worth about $29,000. Vision Financial Markets LLC raised its position in shares of Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after acquiring an additional 200 shares during the period. Finally, Ameriflex Group Inc. raised its position in shares of Clorox by 1,436.8% in the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after acquiring an additional 273 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. UBS Group decreased their price objective on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Jefferies Financial Group reduced their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Wells Fargo & Company reduced their price target on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, May 18th. Finally, The Goldman Sachs Group restated a “sell” rating and set a $83.00 price target on shares of Clorox in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $103.40.

Clorox Stock Down 1.0%

Shares of NYSE CLX opened at $89.10 on Tuesday. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $132.03. The stock has a market cap of $10.77 billion, a PE ratio of 14.46, a P/E/G ratio of 0.47 and a beta of 0.59. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The company has a 50-day moving average of $98.11 and a 200 day moving average of $105.71.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the prior year, the company earned $1.45 EPS. Clorox’s revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, sell-side analysts predict that The Clorox Company will post 5.61 EPS for the current fiscal year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.